Interventions to improve the appropriate use of polypharmacy for older people

A Rankin, CA Cadogan, SM Patterson… - Cochrane Database …, 2018 - cochranelibrary.com
Background Inappropriate polypharmacy is a particular concern in older people and is
associated with negative health outcomes. Choosing the best interventions to improve …

Interventions to improve the appropriate use of polypharmacy in older people: a Cochrane systematic review

JA Cooper, CA Cadogan, SM Patterson, N Kerse… - BMJ open, 2015 - bmjopen.bmj.com
Objective To summarise the findings of an updated Cochrane review of interventions aimed
at improving the appropriate use of polypharmacy in older people. Design Cochrane …

Polypharmacy management in the older adults: a scoping review of available interventions

M Kurczewska-Michalak, P Lewek… - Frontiers in …, 2021 - frontiersin.org
Background: Polypharmacy paves the way for non-adherence, adverse drug reactions,
negative health outcomes, increased use of healthcare services and rising costs. Since it is …

[HTML][HTML] Adverse outcomes of polypharmacy in older people: systematic review of reviews

LE Davies, G Spiers, A Kingston, A Todd… - Journal of the American …, 2020 - Elsevier
Objective Polypharmacy is widespread among older people, but the adverse outcomes
associated with it are unclear. We aim to synthesize current evidence on the adverse health …

Core outcome set for trials aimed at improving the appropriateness of polypharmacy in older people in primary care

A Rankin, CA Cadogan, C ın Ryan… - Journal of the …, 2018 - Wiley Online Library
OBJECTIVES To develop a core outcome set (COS) for use in effectiveness trials of
interventions aiming to improve the appropriateness of polypharmacy in older people in …

Polypharmacy in chronic diseases–reduction of inappropriate medication and adverse drug events in older populations by electronic decision support (PRIMA-eDS) …

A Sönnichsen, US Trampisch, A Rieckert, G Piccoliori… - Trials, 2016 - Springer
Background Multimorbidity is increasing in aging populations with a corresponding increase
in polypharmacy as well as inappropriate prescribing. Depending on definitions, 25-50% of …

Guidance to manage inappropriate polypharmacy in older people: systematic review and future developments

D Stewart, A Mair, M Wilson, P Kardas… - Expert opinion on …, 2017 - Taylor & Francis
Introduction: Single disease state led evidence-based guidelines do not provide sufficient
coverage of issues of multimorbidities, with the cumulative impact of recommendations often …

Reduction of polypharmacy in the elderly: a systematic review of the role of the pharmacist

V Rollason, N Vogt - Drugs & aging, 2003 - Springer
Polypharmacy in the elderly complicates therapy, increases cost, and is a challenge for
healthcare agencies. In the context of the evolving role of the pharmacist, this systematic …

International Group for Reducing Inappropriate Medication Use & Polypharmacy (IGRIMUP): position statement and 10 recommendations for action

D Mangin, G Bahat, BA Golomb, LH Mallery… - Drugs & aging, 2018 - Springer
Globally, the number of drug prescriptions is increasing causing more adverse drug events,
which is now a significant cause of mortality, morbidity, and disability that has reached …

Deprescribing trials: methods to reduce polypharmacy and the impact on prescribing and clinical outcomes

D Gnjidic, DG Le Couteur… - Clinics in geriatric …, 2012 - geriatric.theclinics.com
There are many challenges to ensuring good outcomes from the pharmacologic
management of older adults. With advancing age, the increased prevalence of diseases …